NCT05391425

The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function

The Effect of Solifenacin Used for Lower Urinary Tract Symptoms on Sexual Function in Premenopausal vs Postmenopausal Women: A Prospective Observational Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 150 (estimated)
• Sponsor: Istanbul University · Academic / Other
• Sex: Female
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

This study aims to determine whether Solifenacine used for lower urinary tract symptoms improves sexual function and if so does this improvement differs between premenopausal and postmenopausal women.

Detailed description

Solifenacin is an anticholinergic drug that is commonly used for lower urinary tract symptoms such as urgency, frequency and urge urinary incontinence. Solifenacin use and sexual function improvement is presented in some research, but the correlation between the improvement in sexual function and LUTS symptoms is yet not investigated. Also the effect on sexual function in premenopausal vs postmenopausal women are unknown.

Conditions

• Urge Incontinence
• Urgency-frequency Syndrome

Interventions

Type	Name	Description
OTHER	no intervention	no intervention planned, since it is an observational study

Timeline

• Start date: 2021-06-03
• Primary completion: 2023-06-03
• Completion: 2024-06-03
• First posted: 2022-05-26
• Last updated: 2022-05-26

Locations

1 site across 1 country: Turkey (Türkiye)